Pharmaceutical and Biotechnological Companies Are Expected to Account for the Largest Share of the Global Cell-Based Assays Market in 2017
The report "Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022", The cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4% during the forecast period from 2017 to 2022. Factors driving the growth of this market are the increasing incidence of chronic disorders, growing availability of funds...
View full press release